Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA excision repair protein ERCC-5 (commonly known as XPG, encoded by ERCC5) is a single-strand specific structure-specific DNA endonuclease central to nucleotide excision repair (NER), base excision repair (BER), and transcription-coupled repair (TCR)[1][2][3][5]. XPG makes a critical 3' incision at sites of DNA damage, particularly following UV-induced lesions, and also acts as a scaffold coordinating the assembly of multi-protein DNA repair complexes[1][2][3]. Loss-of-function mutations in ERCC5 cause rare autosomal recessive syndromes including xeroderma pigmentosum group G (XP-G, highly UV-sensitive, cancer-prone), Cockayne syndrome (developmental and neurodegenerative, without cancer predisposition), and cerebro-oculo-facio-skeletal syndrome (COFS3)[1][2][4]. In addition to its endonuclease activity, XPG binds and distorts DNA repair 'bubble' intermediates, facilitating the correct repair of lesions and interfacing with key genes involved in homologous recombination and replication fork protection (e.g., BRCA1/2, RAD51)[3]. It is part of the FEN nuclease superfamily and mutations manifest through loss of either its catalytic function, structural integrity, or interaction capacity, leading to genomic instability, disease, and increased sensitivity to DNA-damaging conditions[1][2][3][5].
Cleavage of damaged DNA 3' to lesion during excision repair; scaffolding for DNA repair protein complexes; DNA bubble binding and destabilization; stimulation of other repair enzymes (e.g., NTHL1 in BER); interaction with transcription and replication machinery
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA excision repair protein ERCC-5 (ERCC5).